Octave Specialty (OSG) Other Accumulated Expenses (2016 - 2026)

Octave Specialty's Other Accumulated Expenses history runs 10 years deep, the most recent figure standing at $487.3 million for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 30.6% year-over-year to $487.3 million in Q1 2026; TTM through Mar 2026 was $487.3 million, a 30.6% increase from a year earlier, with the FY2025 full-year figure at $460.0 million, up 31.78% from the prior year.
• Other Accumulated Expenses rose to $487.3 million in Q1 2026 per OSG's latest filing, from $460.0 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $938.0 million in Q3 2024 and bottomed at $89.9 million in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $437.5 million (2025), against an average of $496.1 million.
• Across the five-year window, Other Accumulated Expenses slumped 94.15% in 2022 and surged 119.21% in 2023, its largest moves.
• Year by year, Other Accumulated Expenses stood at $89.9 million in 2022, then surged by 119.21% to $197.1 million in 2023, then surged by 77.11% to $349.1 million in 2024, then soared by 31.78% to $460.0 million in 2025, then rose by 5.93% to $487.3 million in 2026.
• Per Business Quant, the three latest OSG Other Accumulated Expenses figures stand at $487.3 million (Q1 2026), $460.0 million (Q4 2025), and $437.5 million (Q3 2025).